🧬 Their work highlights miR-92a inhibition as a promising therapeutic strategy against #MASLD progression & #PortalHpertension, demonstrating reduced fibrosis, inflammation, hepatocellular injury, and portal pressure in preclinical models.
#EASL2026 #LiverDisease #TranslationalResearch
#EASL2026 #LiverDisease #TranslationalResearch
May 30, 2026 at 5:52 PM
🧬 Their work highlights miR-92a inhibition as a promising therapeutic strategy against #MASLD progression & #PortalHpertension, demonstrating reduced fibrosis, inflammation, hepatocellular injury, and portal pressure in preclinical models.
#EASL2026 #LiverDisease #TranslationalResearch
#EASL2026 #LiverDisease #TranslationalResearch